These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 26608199)

  • 1. Technical Aspects Related to the Analysis of Circulating microRNAs.
    Butz H; Patócs A
    Exp Suppl; 2015; 106():55-71. PubMed ID: 26608199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA Biomarkers of Toxicity in Biological Matrices.
    Harrill AH; McCullough SD; Wood CE; Kahle JJ; Chorley BN
    Toxicol Sci; 2016 Aug; 152(2):264-72. PubMed ID: 27462126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing sample and miRNA profile quality in serum and plasma or other biofluids.
    Blondal T; Jensby Nielsen S; Baker A; Andreasen D; Mouritzen P; Wrang Teilum M; Dahlsveen IK
    Methods; 2013 Jan; 59(1):S1-6. PubMed ID: 23036329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standardization procedure for plasma biomarker analysis in rat models of epileptogenesis: Focus on circulating microRNAs.
    van Vliet EA; Puhakka N; Mills JD; Srivastava PK; Johnson MR; Roncon P; Das Gupta S; Karttunen J; Simonato M; Lukasiuk K; Gorter JA; Aronica E; Pitkänen A
    Epilepsia; 2017 Dec; 58(12):2013-2024. PubMed ID: 28960286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The miRNA Mirage: How Close Are We to Finding a Non-Invasive Diagnostic Biomarker in Endometriosis? A Systematic Review.
    Agrawal S; Tapmeier T; Rahmioglu N; Kirtley S; Zondervan K; Becker C
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29463003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Key methodological challenges in detecting circulating miRNAs in different biofluids.
    Mestry C; Ashavaid TF; Shah SA
    Ann Clin Biochem; 2023 Jan; 60(1):14-26. PubMed ID: 36113172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating miRNAs as biomarkers for endocrine disorders.
    Butz H; Kinga N; Racz K; Patocs A
    J Endocrinol Invest; 2016 Jan; 39(1):1-10. PubMed ID: 26015318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ExcellmiRDB for translational genomics: a curated online resource for extracellular microRNAs.
    Barupal JK; Saini AK; Chand T; Meena A; Beniwal S; Suthar JR; Meena N; Kachhwaha S; Kothari SL
    OMICS; 2015 Jan; 19(1):24-30. PubMed ID: 25562198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic, prognostic and predictive value of cell-free miRNAs in prostate cancer: a systematic review.
    Endzeliņš E; Melne V; Kalniņa Z; Lietuvietis V; Riekstiņa U; Llorente A; Linē A
    Mol Cancer; 2016 May; 15(1):41. PubMed ID: 27189160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methodological considerations for measuring biofluid-based microRNA biomarkers.
    Chorley BN; Atabakhsh E; Doran G; Gautier JC; Ellinger-Ziegelbauer H; Jackson D; Sharapova T; Yuen PST; Church RJ; Couttet P; Froetschl R; McDuffie J; Martinez V; Pande P; Peel L; Rafferty C; Simutis FJ; Harrill AH
    Crit Rev Toxicol; 2021 Mar; 51(3):264-282. PubMed ID: 34038674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical relevance of circulating cell-free microRNAs in ovarian cancer.
    Nakamura K; Sawada K; Yoshimura A; Kinose Y; Nakatsuka E; Kimura T
    Mol Cancer; 2016 Jun; 15(1):48. PubMed ID: 27343009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variability in, variability out: best practice recommendations to standardize pre-analytical variables in the detection of circulating and tissue microRNAs.
    Khan J; Lieberman JA; Lockwood CM
    Clin Chem Lab Med; 2017 May; 55(5):608-621. PubMed ID: 28306519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurements Methods for the Development of MicroRNA-Based Tests for Cancer Diagnosis.
    Precazzini F; Detassis S; Imperatori AS; Denti MA; Campomenosi P
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33503982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNAs as potential biomarkers in cancer: opportunities and challenges.
    Lan H; Lu H; Wang X; Jin H
    Biomed Res Int; 2015; 2015():125094. PubMed ID: 25874201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The beagle dog MicroRNA tissue atlas: identifying translatable biomarkers of organ toxicity.
    Koenig EM; Fisher C; Bernard H; Wolenski FS; Gerrein J; Carsillo M; Gallacher M; Tse A; Peters R; Smith A; Meehan A; Tirrell S; Kirby P
    BMC Genomics; 2016 Aug; 17():649. PubMed ID: 27535741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of circulating microRNAs as diagnostic biomarkers in colorectal cancer.
    Clancy C; Joyce MR; Kerin MJ
    Cancer Biomark; 2015; 15(2):103-13. PubMed ID: 25547322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microfluidic primer extension assay.
    Beier M; Boisguérin V
    Methods Mol Biol; 2012; 822():143-52. PubMed ID: 22144197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating microRNAs as novel biomarkers for bone diseases - Complex signatures for multifactorial diseases?
    Hackl M; Heilmeier U; Weilner S; Grillari J
    Mol Cell Endocrinol; 2016 Sep; 432():83-95. PubMed ID: 26525415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can circulating miRNAs live up to the promise of being minimal invasive biomarkers in clinical settings?
    Keller A; Meese E
    Wiley Interdiscip Rev RNA; 2016; 7(2):148-56. PubMed ID: 26670867
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.